Beachbum3232 Tuesday, 06/30/20 04:25:53 PM Re: Jcolt post# 89144 Post # of 171389 Couldn't agree with you more. And let's not forget investors in lifescience companies are easily manipulated when talking about clinical trial outcomes. Easy to try and poke holes in study design/enrollment/etc but in the end it's about the results---so longs need to hold the line and not forget why you bought into this company in the first place. It's the science and potential to save lives. In my mind CVD 19 was an unexpected event both for victims and for potential treatments---I was invested in this company long before Covid. Like you, I bought in because of the other indications leron can treat. This company has a lot going for it which outweighs some erroneous content or content taken out of context being published out there.